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Meeting report
Can music be decomposed to single notes on a piece of 
paper? Can life be fully understood by the function of 
genes in isolation? Th ese are some of the questions that 
Denis Noble (University of Oxford, UK) posed in one of 
the more philosophical keynote addresses of this year’s 
European Conference on Computational Biology 
(ECCB). Noble, a famed critic of genetic reductionism, in 
concert with renowned guitarist Christoph Denoth, set 
out to explore how synergy begets complexity both in art 
and in science. And in doing so, he captured a central 
theme of the conference: holism.
From gene prediction to comparative genomics to 
protein structure prediction, the early days of post-
genomic bioinformatics research were arguably charac-
terized by a reductionist approach to understanding life. 
Systems biology, on the other hand, started on the 
opposite end of the spectrum, attempting to directly 
model complex behavior arising from biomolecular inter-
play, largely abstracted from the individual components. 
In this post-ENCODE era, in which tremendous progress 
has been made in understanding each biomolecule 
individually, the focus now seems to have shifted toward 
a middle ground: leveraging the treasure trove of 
information about the nodes of the network to elucidate 
the intricate web of interactions represented by the 
network edges.
Given the sustained development of next-generation 
sequencing technologies and their essential role in the 
ascendancy of genomics, it is perhaps surprising that 
talks on this subject were conspicuously scarce at ECCB. 
However, this is not to say that genomics was not 
pervasive throughout the conference; it was, from 
keynotes to posters, just indirectly so. Sequencing 
technologies appear to be maturing into stable tools that 
are ubiquitously used to obtain deep knowledge of 
biomolecules themselves, as well as intermolecular 
relationships. As a silent partner, genomics is providing 
both the starting point and the means for investigating 
networks, but without stealing the spotlight.
Genetic interactions: within genomes
Th e systematic identifi cation and characterization of 
genome-wide genetic interactions is one area that has 
already been transformed by the availability of sequence 
data for multiple species. Colm Ryan (University of 
California, San Francisco, USA) compared experimentally 
derived epistasis maps of the fi ssion yeast Schizosaccharo-
myces pombe and the budding yeast Saccharomyces 
cerevisiae to show that the overall level of genetic cross-
talk between diff erent biological processes tends to be 
more conserved than the underlying interactions. He 
further demonstrated how epistasis maps can be used to 
annotate uncharacterized genes, drawing on the observa-
tion that genes with similar genetic interaction profi les 
are often involved in the same functional pathway. 
Similar approaches may be used as a model for genetic 
interaction analysis in more complex organisms, in an 
eff ort to understand not only biological functions, but 
also the mechanisms that underlie disease phenotypes. 
Philipp Bucher (École Polytechnique Fédérale de 
Lausanne, Switzerland) exploited lineage-specifi c whole-
genome duplication events in teleost fi sh (including 
zebrafi sh and puff erfi sh lineages) to investigate the post-
duplication fate of ultraconserved non-coding elements. 
Th ese elements tend to be organized in large clusters 
around developmental genes, and were found mostly to 
be retained together in only one of the two genome 
copies. Th is winner-takes-all scenario suggests that ultra-
conserved non-coding elements operate as part of a 
dense cooperativity network, which could be responsible 
for their high levels of conservation.
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Genetic interactions: between genomes
In a tour de force keynote presentation focusing on the 
social organization of fire ants (Solenopsis invicta), 
Laurent Keller (University of Lausanne, Switzerland) 
demonstrated that an ant’s behavior is determined not 
only by its own genome but also by other genomes in the 
population. By way of example, Keller described what 
might be called a selfish allele in a 13.9  Mbp non-
recombining region, encoding the odorant protein Gp-9, 
that regulates its own frequency by mediating altruistic 
and aggressive instincts. Michal Linial (The Hebrew 
University of Jerusalem, Israel) explored interactions 
between virus and host genomes from an evolutionary 
perspective. Linial demonstrated how both amino acid 
and codon usage of viral proteomes have adapted to 
maximize translational efficiency in specific host environ-
ments. Linial also showed that host-acquired genes in 
virus genomes tend to have fewer protein domains and 
shorter linker regions than their host counterparts. 
Understanding these evolutionary adaptations may prove 
essential to the effective management of viral infections.
Protein-RNA interactions
The recently published results of the ENCODE project 
established that at least three quarters of the human 
genome is capable of being transcribed. One approach to 
understanding the functional role of this pervasive 
transcription may be the identification of new RNA-
binding proteins, as presented by Cristoph Dieterich 
(Max Delbrück Center for Molecular Medicine, Germany). 
By purifying proteins that have been cross-linked to 
polyadenylated mRNA, followed by quantitative mass 
spectrometry, Dieterich identified 797  mRNA-bound 
proteins, one third of which were previously unknown 
and likely participate in post-transcriptional gene-regu-
lation networks. Moreover, Dieterich used PAR-CLIP to 
sequence the mRNA-binding sites of these proteins. 
Mihaela Zavolan (Biozentrum, Switzerland) also reported 
a novel application of PAR-CLIP, in which the Argonaute 
component of the RISC complex was used as bait to 
discover non-canonical microRNA (miRNA)-target inter-
actions. Intriguingly, Zavolan showed how a single 
miRNA molecule (miR-294) can target components of 
the chromatin-remodeling complex and prevent differen-
tiation in embryonic stem cells, thus concluding that a 
handful of miRNAs may be sufficient to determine cell 
fate.
Protein-protein interactions
Although protein-protein interaction (PPI) networks 
have been extremely valuable as a starting point for 
modeling cellular processes, it is well known that PPI 
databases have a high false-positive rate, while omitting 
many genuine interactions. The gold standard for the 
field, as described by Barry Honig (Columbia University, 
USA), is a three-dimensional structure of a complex that 
incorporates the interacting proteins, but this level of 
confirmation is available for less than 0.5% of all recorded 
PPIs. Honig presented a computationally efficient 
method for superimposing homologous proteins onto 
known structural interactions in order to generate inter-
action models, which are subsequently combined with 
co-expression and functional similarity information. This 
approach makes clever use of homology to known 
structures; however, as Chris Sander (Memorial Sloan-
Kettering Cancer Center, USA) noted, only half of the 
well-characterized protein families in the Pfam database 
have a known three-dimensional structure for any of 
their members. To address this limitation, Sander identi-
fied co-evolving residues from multiple sequence align-
ments in order to predict residue-residue proximity in 
folded protein structures. Philip Kim (University of 
Toronto, Canada) illustrated the tissue-specific nature of 
PPI networks by monitoring how alternative splicing 
events impact upon them. Kim presented evidence that 
as much as a third of all tissue-specific alternatively spliced 
exons lead to differential PPI through both the creation of 
new and the destruction of existing interactions.
Protein-drug interactions
Chemogenomics is an emerging research area that is 
focused on identifying novel drug-protein interactions by 
screening libraries of small molecules against the 
proteome, through the computational analysis of high-
through put data. Yoshihiro Yamanishi (Kyushu Univer sity, 
Japan) presented a method, based on sparsity-induced 
binary classifiers, that incorporates data on the chemical 
structures of drugs, genomic information about target 
proteins and all known protein-ligand interactions across 
different protein families into a predictive model. The 
model can predict underlying interactions between drug 
chemical substructures and protein functional sites, 
which are involved in drug-target interaction networks. 
With a view to understanding and minimizing drug side 
effects in patients, Sayaka Mizutani (Kyoto University, 
Japan) presented an approach for integrating drug side 
effect data with drug-protein binding information, using 
sparse canonical correlation. This technique was used to 
derive highly correlated sets of drug-targeted proteins 
and side effects, along with the drugs that drive their 
correlation. Such methods can play an important role in 
predicting potential side-effects and their mediating 
pathways even at the drug design phase.
Conclusions
The opening keynote lecture of ECCB was delivered by 
Nobel laureate Aaron Ciechanover (Technion - Israel 
Institute of Technology, Israel) who described his 
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magnum opus: unraveling the previously unknown 
cellular mechanism of protein degradation. Ciechanover 
outlined many aspects of ubiquitin-mediated protein 
degradation, including the role of E3 ubiquitin ligases in 
ensuring high target specificity. He further highlighted 
the link between dysregulation of the ubiquitin-
proteasome pathway and disease. Various levels of this 
pathway have been identified as drug targets to treat or 
suspend the progression of diseases such as myeloma, 
leukemia and viral encephalitis. While this talk was 
inspiring, the fact that these discoveries were made 
without the assistance of high-throughput technologies 
or bioinformatics was sobering, and raises the question 
of whether computational analyses of high-throughput 
data can lead to the elucidation of still unknown, funda-
mental cellular mechanisms. In other words, when will 
bioinformatics have its Nobel Prize moment? The talks 
presented at this conference suggest that by transforming 
information on complex biomolecular interactions, 
obtained at high cellular and temporal resolution, into 
sequence data, bioinformaticians may be well on the way 
to achieving such a feat.
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